| Term 
 | Definition 
 
        | Mech: Enhances GABA by blocking re-uptake into presynaptic neurons; INHIBITS GAT-1 APP: Focal tonic-clonic seizures (adjunct)
 AE: Unexplained sudden death, psychosis, depression, sedation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mech: Blocks GABA Conversion (BLOCKS GABA TRANSAMINASE) and increases intracellular GABA and increased secretion of GABA into the synaptic cleft APP: Focal tonic-clonis seizures (adjunct)
 AE: Retinal Atrophy, angioedema
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mech: Activates GABA receptor APP: USED ONLY IN EXPERIMENTS
 TC: derived from hallucinogenic Amanita Muscara mushrooms
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mech: Activates GABA receptor Investigational agent for treatment of insomnia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mech: Competitive Antagonist of GABA receptor APP: EXPERIMENTAL use only
 TC: Produce epileptic convulsions
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mech: Non-competitive Antagonist of GABA receptor APP: EXPERIMENTAL use only
 TC: Produce epileptic convulsions
 |  | 
        |  | 
        
        | Term 
 
        | Clorazepate (short acting) and Chlordiazepoxide (long lasting) |  | Definition 
 
        | Mech:Weak allosteric agonist of the GABA receptor (INCREASE THE FREQUENCY OF RECEPTOR OPENING) APP: ALCOHOL WITHDRAWAL and ANXIETY
 AE: RESPIRATORY DISTRESS, AGITATION, apnea desaturation in pediatric patients
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mech:Weak allosteric agonist of the GABA receptor (INCREASE THE FREQUENCY OF RECEPTOR OPENING) APP: Focal and tonic-clonic seizures, Status epilepticus, and Amnesia induction
 AE: RESPIRATORY DISTRESS, AGITATION, apnea desaturation in pediatric patients
 |  | 
        |  | 
        
        | Term 
 
        | Short acting Benzodiazepine |  | Definition 
 
        | Clorazepate, Midazolam, Triazolam, Zolpidem |  | 
        |  | 
        
        | Term 
 
        | Zolpidem (slow), Estazolam and Temazepam (intermediate), and Flurazepam and Quazepam (long lasting) |  | Definition 
 
        | Mech:Weak allosteric agonist of the GABA receptor (INCREASE THE FREQUENCY OF RECEPTOR OPENING APP: Insomnia
 AE: RESPIRATORY DISTRESS, AGITATION, apnea desaturation in pediatric patients
 |  | 
        |  | 
        
        | Term 
 
        | Intermediate acting Benzodiazepine |  | Definition 
 
        | Alprazolam, Estazolam, Lorazepam, Temazapam |  | 
        |  | 
        
        | Term 
 
        | Alprazolam (Intermediate acting) |  | Definition 
 
        | Mech: Weak allosteric agonist of the GABA receptor (INCREASE THE FREQUENCY OF RECEPTOR OPENING) APP: Anxiety
 AE: RESPIRATORY DISTRESS, AGITATION, apnea desaturation in pediatric patients
 Contra: Glaucomas
 TC: Decreased levels when used with Carbamazepine and phenobarbital
 TC: Patients with impaired hepatic function may experience prolonged effects
 |  | 
        |  | 
        
        | Term 
 
        | Lorazelam (Intermediate acting) |  | Definition 
 
        | APP: Focal tonic-clonic seizures, STATUS EPILEPTICUS, Amnesia induction, Anxiety, INSOMNIA Mech: Weak allosteric agonist of the GABA receptor (INCREASE THE FREQUENCY OF RECEPTOR OPENING)
 AE: RESPIRATORY DISTRESS, AGITATION, apnea desaturation in pediatric patients
 Contra: Glaucomas
 TC: Decreased levels when used with Carbamazepine and phenobarbital
 TC: Patients with impaired hepatic function may experience prolonged effects
 |  | 
        |  | 
        
        | Term 
 
        | Clonazepam (long lasting) |  | Definition 
 
        | APP: Absence seizures, Anxiety, Mech: Weak allosteric agonist of the GABA receptor (INCREASE THE FREQUENCY OF RECEPTOR OPENING)
 AE: RESPIRATORY DISTRESS, AGITATION, apnea desaturation in pediatric patients
 Contra: Glaucomas
 TC: Decreased levels when used with Carbamazepine and phenobarbital
 TC: Patients with impaired hepatic function may experience prolonged effects
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | APP: Focal clonic-tonic seizures, Amnesia induction, Anxiety, Alcohol withdrawal Mech: Weak allosteric agonist of the GABA receptor (INCREASE THE FREQUENCY OF RECEPTOR OPENING)
 AE: RESPIRATORY DISTRESS, AGITATION, apnea desaturation in pediatric patients
 Contra: Glaucomas
 TC: Decreased levels when used with Carbamazepine and phenobarbital
 TC: Patients with impaired hepatic function may experience prolonged effects
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mech: Benzodiazepine antagonist APP: Reverse effects of benzodiazepines
 AE: Seizure, cardiac arrhythmias, and diaphoresis
 CI: Trycyclic antidepressant overdose
 CI: intracranial hypertension
 TC: If patient is addicted to benzodiazepines then the drug can induce a severe withdrawal syndrome
 |  | 
        |  | 
        
        | Term 
 
        | Methohexital and Thiopental |  | Definition 
 
        | Mech: At high levels acts as a GABA receptor agonist APP: Induction and maintenance of anesthesia
 AE: SJ syndrome, bone marrow suppression, hepatotoxicity, osteopenia
 CI: Porphyria, Severe liver dysfunction, respiratory disease
 TC: Metabolism increased with P450 activators (thiopental)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mech: At high levels acts as a GABA receptor agonist APP: Induction and maintenance of anesthesia, Insomnia, Status epileptics
 AE: SJ syndrome, bone marrow suppression, hepatotoxicity, osteopenia
 CI: Porphyria, Severe liver dysfunction, respiratory disease
 TC: Metabolism increased with P450 activators (thiopental)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mech: At high levels acts as a GABA receptor agonist APP: Induction and maintenance of anesthesia, Insomnia, and INCREASED INTRACRANIAL PRESSURE
 AE: SJ syndrome, bone marrow suppression, hepatotoxicity, osteopenia
 CI: Porphyria, Severe liver dysfunction, respiratory disease
 TC: Metabolism increased with P450 activators (thiopental)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mech: At high levels acts as a GABA receptor agonist APP: Insomnia
 AE: SJ syndrome, bone marrow suppression, hepatotoxicity, osteopenia
 CI: Porphyria, Severe liver dysfunction, respiratory disease
 TC: Metabolism increased with P450 activators (thiopental)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mech: At high levels acts as a GABA receptor agonist APP: Status epilepticus, Insomnia
 AE: SJ syndrome, bone marrow suppression, hepatotoxicity, osteopenia
 CI: Porphyria, Severe liver dysfunction, respiratory disease
 TC: Metabolism increased with P450 activators (thiopental)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mech: At high levels acts as a GABA receptor agonist APP: Refractory epilepsy (especially tonic-clonic seizures), Insomnia
 AE: SJ syndrome, bone marrow suppression, hepatotoxicity, osteopenia
 CI: Porphyria, Severe liver dysfunction, respiratory disease
 TC: Metabolism increased with P450 activators (thiopental)
 TC: Undergoes both renal and hepatic clearance
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mech: modulation of ion channels in GABA APP: Induction of anesthesia
 AE: Cardiovascular and respiratory depression
 TC: Mild cardiopulmonary depression
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mech: modulation of ion channels in GABA APP: Induction and maintenance of anesthesia
 AE: Cardiovascular and respiratory depression
 TC: Mild cardiopulmonary depression
 TC: USEFUL IN SHORT DAY-SURGERY
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mech: GABA receptor agonist APP: Spasticity
 AE: Coma, seizures, constipation, and death after abrupt    withdrawal
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mech: NMDA receptor antagonist and black voltage-gated sodium channels APP: ALS
 AE: Neutropenia, cardiac arrest, hepatotoxicity, and respiratory depression
 TC: Prolongs survival and decreases progression
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mech: NMDA receptor antagonist APP: Alzheimer's Disease
 AE: Hypertension, constipation, dizziness, and headache
 TC: Slows progression
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mech: NMDA receptor antagonist APP: Parkinson's and Influenze A prophylaxis and infection
 AE: Neuroleptic malignant syndrome, suicidal ideation, orthostatic hypotension, insomnia, and hallucinations
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mech: NMDA receptor antagonist and black voltage-gated sodium channels APP: Focal tonic-clonic seizures, atypical absence seizures, and Bipolar 1 disorders
 AE: SJ syndrome, toxic epidermal necrolysis, bone marrow suppression, amnesia, and angioedema
 TC: BLOCKS VOLTAGE GATED SODIUM CHANNELS (REDUCING CONDUCTANCE), 3rd DRUG OF CHOICE FOR ABSENCE SEIZURES
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mech: NMDA receptor antagonist and black voltage-gated sodium channels APP: Refractory epilepsy (especially focal tonic-clonic seizures)
 AE: SJ syndrome, aplastic anemia, bone marrow suppression, hepatic necrosis, amnesia, and angioedema
 TC: BLOCKS VOLTAGE GATED SODIUM CHANNELS (REDUCING CONDUCTANCE)
 TC: Lacks the behavioral changes of other NMDA antagonists
 TC: LIMITED TO PATIENTS WITH EXTREMELY REFRACTORY EPILEPSY
 |  | 
        |  |